BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35785613)

  • 1. Integrating peer support services into primary care-based OUD treatment: Lessons from the Penn integrated model.
    Harris RA; Campbell K; Calderbank T; Dooley P; Aspero H; Maginnis J; O'Donnell N; Coviello D; French R; Bao Y; Mandell DS; Bogner HR; Lowenstein M
    Healthc (Amst); 2022 Sep; 10(3):100641. PubMed ID: 35785613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol.
    Harris RA; Mandell DS; Kampman KM; Bao Y; Campbell K; Cidav Z; Coviello DM; French R; Livesey C; Lowenstein M; Lynch KG; McKay JR; Oslin DW; Wolk CB; Bogner HR
    Contemp Clin Trials; 2021 Apr; 103():106325. PubMed ID: 33631356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
    Dela Cruz AM; Walker R; Pipes R; Wakhlu S; Trivedi MH
    Addict Sci Clin Pract; 2021 Feb; 16(1):12. PubMed ID: 33608060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City.
    Truong C; Krawczyk N; Dejman M; Marshall-Shah S; Tormohlen K; Agus D; Bass J
    Addict Behav; 2019 Jun; 93():14-19. PubMed ID: 30682677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.
    Banta-Green CJ; Owens MD; Williams JR; Sears JM; Floyd AS; Williams-Gilbert W; Kingston S
    Addict Sci Clin Pract; 2022 Jul; 17(1):34. PubMed ID: 35799210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices.
    Zittleman L; Curcija K; Nease DE; Fisher M; Miriam Dickinson L; Thomas JF; Espinoza A; Sutter C; Ancona J; Holtrop JS; Westfall JM
    Ann Fam Med; 2022; 20(1):18-23. PubMed ID: 35074763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stigma towards opioid use disorder in primary care remain a barrier to integrating software-based measurement based care.
    Dela Cruz AM; Karns-Wright T; Kahalnik F; Walker R; Lanham HJ; Potter JS; Trivedi MH
    BMC Psychiatry; 2023 Oct; 23(1):776. PubMed ID: 37875835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.
    Kawasaki S; Francis E; Mills S; Buchberger G; Hogentogler R; Kraschnewski J
    J Subst Abuse Treat; 2019 Nov; 106():58-64. PubMed ID: 31540612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
    Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
    J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating substance use care into primary care for adolescents and young adults: Lessons learned.
    Bagley SM; Hadland SE; Schoenberger SF; Gai MJ; Topp D; Hallett E; Ashe E; Samet JH; Walley AY
    J Subst Abuse Treat; 2021 Oct; 129():108376. PubMed ID: 34080547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment.
    Clemency BM; Hoopsick RA; Burnett SJ; Kahn LS; Lynch JJ
    West J Emerg Med; 2022 Jun; 23(4):451-460. PubMed ID: 35980408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
    Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
    Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.